Acambis plc
Pharma company releases third quarter 2004 results
Published in Pharma Investments, Ventures and Law Weekly, December 26th, 2004
Following the U.S. Food and Drug Administration's (FDA) decision to lift the clinical hold on trials of our investigational ACAM2000 smallpox vaccine, Acambis has been able to resume the process of deliveries of the vaccine to the U.S. and other governments. However, as the decision was not made until late September, there was limited financial impact in the third quarter.
The company is now closed out the clinical portion of the two phase III trials and work is progressing well on the serological analysis of samples from the trials. Following...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly
More Articles from Pharma Investments, Ventures and Law Weekly
- Access Pharmaceuticals, Inc.
Pharmaceutical company reports loss of $0.16 per share - Alchemia Limited
Pharma company discusses financial results - Amgen, Inc.
Biotech company announces offer of $2B in two series of senior notes - Antares Pharma, Inc.
Pharmaceutical firm reports loss of $0.06 per share - Astralis, Ltd.
Biotech company reports loss of $0.02 per share - Australian Cancer Technology
Australian biotech firm confirms fundraising - More from this issue of Pharma Investments, Ventures and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
